Editor's Note The “surgical pause”—a means of validating whether surgery is truly safe for patients deemed to be “frail” before starting a procedure—significantly reduces mortality rates and is changing practices at more than 50 Veterans Administration (VA) hospitals, the Pittsburgh Post-Gazette reported August 18. Developed by VA surgeons Daniel Hall…
Editor's Note The US Food and Drug Administration (FDA) has designated Defibtech, LLC’s recall of RMU-2000 ARM XR Chest Compression Devices as Class 1, the most severe category indicating serious risk of injury or death. A motor issue could stop compressions in adults whose hearts suddenly stop, according to the…
Editor's Note Recent research sheds new light on addressing two of the most pressing problems for surgical care: handoff communication failures and care bias and inequities leading to adverse—and preventable—events. These problems are the subjects of two separate success stories in the August issue of The Joint Commission Journal…
Editor's Note The US Food & Drug Administration (FDA) has approved immunotherapy durvalumab for perioperative treatment of resectable non-small cell lung cancer (NSCLC), according to an August 15 announcement. The approval is for durvalumab (Imfinzi, AstraZeneca) in combination with platinum-based chemotherapy as a neoadjuvant treatment, followed by durvalumab alone as…
Editor's Note A recent study conducted across 185 hospital wards in England highlights the significant impact of nurse staffing levels and staff composition on patient mortality. Published August 19 in JAMA, the study analyzed data from over 626,000 hospital admissions between 2015 and 2020. It found that low staffing levels…
Editor's Note A recent study, published by Perioperative Medicine on August 13 and conducted at a large US academic tertiary care ambulatory surgery center (ASC), found the incidence of unplanned hospital admissions within 24 hours after a procedure performed at an ASC is “exceptionally” low. The research, which analyzed data…
Editor's Note MD Anderson Cancer Center shared insights on overcoming OR capacity challenges during a session at last year’s OR Manager Conference that highlighted creative solutions to staffing shortages and capacity constraints. With the ongoing pressures exacerbated by COVID-19, which is hitting a peak this summer, MD Anderson has implemented…
Editor's Note The percentage of new mothers without any prenatal care is rising amid an overall decline in US birth rates, according to new data from the Centers for Disease Control and Prevention (CDC). NBC News reported on the data August 21. According to the article, CDC’s National Center for…
Editor's Note Evidence is mounting for the use of antibiotics as a valid alternative to surgery for acute appendicitis, including in pediatric cases, the Washington Post reported August 17. The article details how this treatment—described as a “dark secret” by one expert testifying to its use in the 1950s, prior…
Editor's Note The US Food and Drug Adminstration (FDA) has classified a recall of ICU Medical’s Plum 360, Plum A+ and Plum A+3 infusion pumps as Class 1, the most severe category indicating risk of serious injury or death. According to he agency’s August 20 announcement, the company is updating…